Arbaclofen placarbil

Description: Arbaclofen placarbil( XP19986) is a GABA(B) receptor agonist.Arbaclofen Placarbil is a novel R-baclofen prodrug with improved absorption, distribution, metabolism, and elimination properties compared to R-baclofen. And it can reduce postprandial reflux in patients with gastroesophageal reflux disease. Target: Others. Smiles: [C@@H](CNC(O[C@H](OC(C(C)C)=O)C(C)C)=O)(CC(O)=O)C1=CC=C(Cl)C=C1. References: Erickson CA, Veenstra-Vanderweele JM, Melmed RD, McCracken JT, Ginsberg LD, Sikich L, Scahill L, Cherubini M, Zarevics P, Walton-Bowen K, Carpenter RL, Bear MF, Wang PP, King BH. STX209 (arbaclofen) for autism spectrum disorders: an 8-week open-label study. J Autism Dev Disord. 2014 Apr,44(4):958-64. doi: 10.1007/s10803-013-1963-z. PubMed PMID: 24272415.